Zacks Research Has Bullish Outlook for Allstate Q4 Earnings

The Allstate Co. (NYSE:ALL) – Investment analysts at Zacks Research lifted their Q4 2024 earnings estimates for shares of Allstate in a research report issued on Wednesday, November 13th. Zacks Research analyst Z. Masood now forecasts that the insurance provider will post earnings per share of $4.77 for the quarter, up from their previous forecast of $4.64. The consensus estimate for Allstate’s current full-year earnings is $16.07 per share. Zacks Research also issued estimates for Allstate’s Q1 2025 earnings at $5.11 EPS, Q3 2026 earnings at $4.68 EPS and FY2026 earnings at $18.27 EPS.

Other research analysts also recently issued research reports about the stock. Barclays lifted their price objective on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research report on Thursday, October 31st. TD Cowen upped their price objective on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. Roth Mkm restated a “buy” rating and issued a $200.00 price target on shares of Allstate in a research note on Wednesday, August 14th. Morgan Stanley increased their price target on shares of Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a report on Thursday, November 7th. Finally, BMO Capital Markets increased their target price on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $214.19.

Allstate Price Performance

ALL opened at $196.88 on Friday. The stock has a market cap of $52.13 billion, a P/E ratio of 12.75, a P/E/G ratio of 1.75 and a beta of 0.48. Allstate has a 12 month low of $131.65 and a 12 month high of $201.00. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The company has a fifty day simple moving average of $190.01 and a 200 day simple moving average of $176.72.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion for the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the previous year, the business earned $0.81 EPS. Allstate’s revenue was up 14.7% compared to the same quarter last year.

Allstate Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 1.87%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio is presently 23.83%.

Insider Transactions at Allstate

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 50.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 143,049 shares of company stock valued at $26,106,112. 1.80% of the stock is currently owned by corporate insiders.

Institutional Trading of Allstate

Several institutional investors have recently added to or reduced their stakes in ALL. Geode Capital Management LLC raised its holdings in Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider’s stock worth $1,178,164,000 after purchasing an additional 74,537 shares in the last quarter. LRI Investments LLC lifted its stake in shares of Allstate by 334.8% in the 3rd quarter. LRI Investments LLC now owns 17,388 shares of the insurance provider’s stock valued at $3,298,000 after purchasing an additional 13,389 shares during the period. PYA Waltman Capital LLC raised its holdings in Allstate by 3.5% in the third quarter. PYA Waltman Capital LLC now owns 15,238 shares of the insurance provider’s stock worth $2,890,000 after purchasing an additional 520 shares in the last quarter. SGL Investment Advisors Inc. bought a new stake in shares of Allstate during the 3rd quarter valued at $545,000. Finally, EWA LLC bought a new position in shares of Allstate in the 3rd quarter worth about $242,000. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.